Antiviral discovery for highly pathogenic emerging viruses. (2020)

• Record Type: Book
• Further Information: Note: Edited by César Muñoz-Fontela, Rafael Delgado.
• Editors: Munoz-Fontela, César; Delgado, Rafael
• Contents: Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets;Advances in Prophylaxis and Therapy of Arenavirus Hemorrhagic Fevers;Vaccines and Antiviral Developments for SARS-CoV-2 in the Emergence of the COVID-19 Pandemic;Small-molecule and Synthetically Derived Antivirals for Ebola Virus and Other Filoviruses;Antiviral Strategies for Ebola Virus and other Filoviruses: Antibodies;Vaccine Development in the Midst of Ebolavirus Disease Outbreaks;Remdesivir: Investigational Antiviral Drug with Activity Against Ebola and Other Emerging and Neglected Viruses;Therapeutics Against Nipah and Hendra Virus;Glycomimetics as Promising Inhibitors of Ebola virus, Flavivirus and HIV Infections;Repurposing Approved Drugs to Block Highly Pathogenic Emerging Viruses;Receptors on Primary Phagocytes as Therapeutic Targets Against Highly Pathogenic Emerging Viruses
• Edition: 1st
• Publisher Details: Cambridge : Royal Society of Chemistry
• Publication Date: 2020
• Extent: 1 online resource
• Subjects: 615.7924; Antiviral agents -- Development
• Languages: English
• ISBNs: 9781788016858; 9781839160530
• Related ISBNs: 9781788015646
• Notes: Note: Description based on CIP data; resource not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.